12:00 AM
 | 
Aug 08, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Axanum low dose aspirin/esomeprazole magnesium regulatory update

AstraZeneca said 23 countries in the EU and Norway issued a positive agreement for approval of an MAA for Axanum aspirin/esomeprazole to prevent cardiovascular events in high...

Read the full 114 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >